SCHEMBL106372

SCHEMBL106372

CO[Si](OC)(OC)C1CCC1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL80385 0.94
SCHEMBL93335 0.91
SCHEMBL27028327 0.91
SCHEMBL10012485 0.91
SCHEMBL104590 0.91
SCHEMBL29278695 0.87
SCHEMBL106438 0.87
SCHEMBL5611591 0.82
SCHEMBL32664299 0.82
SCHEMBL28520399 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 480 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260000623-A1 DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES CHAN, Hardy Wai Hong (TW) 2026-01-01 US claimed
CN-112239209-B Drug delivery via pore-modified mesoporous silica nanoparticles 奈力生医股份有限公司 2024-01-12 CN claimed
EP-3766482-B1 DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES NANO TARGETING & THERAPY BIOPHARMA INC (TW) 2023-11-22 EP claimed
CN-107428716-B Catalyst system, olefin polymerization catalyst component comprising at least an internal electron donor compound, and methods of making and using the same 格雷斯公司 2021-05-11 CN claimed
CN-109134720-B External electron donors for olefin polymerization 印度石油有限公司 2021-03-05 CN claimed
US-20210015757-A1 DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES CHAN, Hardy Wai Hong (TW) 2021-01-21 US claimed
EP-3766482-A1 DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES Nano Targeting & Therapy Biopharma Inc. (TW) 2021-01-20 EP claimed
CN-112239209-A Drug delivery through pore-modified mesoporous silica nanoparticles 奈力生医股份有限公司 2021-01-19 CN claimed
US-10689465-B2 External donor for olefin polymerization INDIAN OIL CORPORATION LIMITED (IN) 2020-06-23 US claimed
EP-3653631-A1 PROCESSES FOR THE PREPARATION OF AN OLEFIN POLYMERIZATION CATALYST BASED ON TREATING SOLID ORGANOMAGNESIUM COMPOUNDS WITH TITANIUM MOIETIES INDIAN OIL CORPORATION Ltd. (IN) 2020-05-20 EP claimed
US-20150274857-A1 DISTANCE MEASURING METHOD AND DISTANCE MEASURING ELEMENT INDIAN OIL CORPORATION LIMITED (IN) 2015-10-01 US claimed
EP-2897965-A2 PRECURSOR FOR CATALYST, PROCESS FOR PREPARING THE SAME AND ITS USE THEREOF Indian Oil Corporation Ltd (IN) 2015-07-29 EP claimed
EP-2897966-A2 ORGANOMETALLIC COMPOUND IN SOLID FORM, PROCESS FOR PREPARING THE SAME AND USE THEREOF Indian Oil Corporation Ltd (IN) 2015-07-29 EP claimed
US-20150191553-A1 ORGANOMETALLIC COMPOUND IN SOLID FORM, PROCESS FOR PREPARING THE SAME AND USE THEREOF INDIAN OIL CORPORATION LIMITED (IN) 2015-07-09 US claimed
CN-104662027-A Multicomponent mixture of magnesium alkoxide, magnesium halide and alcohol, method for the production thereof and use thereof in a method for producing a catalyst for olefin polymerization INDIAN OIL CORP LTD 2015-05-27 CN claimed
CN-104583219-A Multi component mixture of magnesiumcoholates, magnesiumhalides and alcohol, processes to make them and their use in processes to make olefin polymerization catalyst INDIAN OIL CORP LTD 2015-04-29 CN claimed
EP-2628745-B1 Silicon-containing surface modifier, resist lower layer film-forming composition containing the same, and patterning process SHINETSU CHEMICAL CO (JP) 2015-03-25 EP claimed
WO-2014045259-A2 PRECURSOR FOR CATALYST, PROCESS FOR PREPARING THE SAME AND ITS USE THEREOF INDIAN OIL CORPORATION LIMITED (IN) 2014-03-27 WO claimed
WO-2014045260-A2 ORGANOMETALLIC COMPOUND IN SOLID FORM, PROCESS FOR PREPARING THE SAME AND USE THEREOF INDIAN OIL CORPORATION LIMITED (IN) 2014-03-27 WO claimed
US-H2060-H1 Cyclobutyl silanes for catalysts useful for making highly isotactic olefin polymers ENGELHARD CORPORATION 2003-03-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260000623-A1 DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES AQP4, ABCB1, SRMS CYP2C9 387/4885TSHR 3081/4885CYP2C19 374/4885
US-20150274857-A1 DISTANCE MEASURING METHOD AND DISTANCE MEASURING ELEMENT MLX, PRDX2, NFXL1 CYP2C9 2365/4885TSHR 2522/4885CYP2C19 3050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.